Company & Sponsor Intelligence
Arizona State University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed1
Countries1
Therapeutic footprint
depression
Indexed studies
NCT00051727Prevention of School Dropout for Mexican American Adolescents
adhd · United StatesPHASE2
adhd · United StatesPHASE2
NCT05881096Effectiveness of START (Startle Adjuvant Rehabilitation Therapy) in Enhancing Arm Function Post-Stroke
stroke · United StatesEARLY_PHASE1
stroke · United StatesEARLY_PHASE1
NCT04706806Effect of Daily Vinegar Ingestion for Four Weeks on Mood State in Healthy College Students
depression · United StatesNA
depression · United StatesNA
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →